Orchid Pharma Company Profile
What is the competitive landscape for ORCHID PHARMA
ORCHID PHARMA has one approved drug.
There are two US patents protecting ORCHID PHARMA drugs.
Summary for Orchid Pharma
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Orchid Pharma: | See patent lawsuits for Orchid Pharma |
Drugs and US Patents for Orchid Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orchid Pharma | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Orchid Pharma | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | 11,124,526 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Orchid Pharma | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Orchid Pharma | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | 7,687,488 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Orchid Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 2046802 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2015067787 | ⤷ Start Trial |
| South Korea | 20160081964 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2008010048 | ⤷ Start Trial |
| Denmark | 2046802 | ⤷ Start Trial |
| Canada | 2929199 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

